Similar antitumor efficacy and weight effects were observed in murine xenograft models with tumor regression occurring at 20 mg/kg BID (Rat1-myr-p110α, Rat1-myr-p110δ, and HBRX2524) (Supplemental Fig. 1A-C). Here, PIK3CD is linked to neoplasm.